XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.2
EPT - Condensed Consolidated Statements of Equity for the three and six months ended June 30, 2023 and 2022 (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Distributions in excess of accumulated earnings
Accumulated other comprehensive income (loss), net
Noncontrolling interest
Balance at period beginning (in shares) at Dec. 31, 2021   65,248        
Balance at period beginning at Dec. 31, 2021 $ 6,176,508 $ 7 $ 6,915,981 $ (916,833) $ (5,552) $ 182,905
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 140,065     130,308   9,757
Change in fair value of derivatives and amortization of swap settlements 31,895       30,820 1,075
Change in fair value of marketable debt securities, net 296       286 10
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   87        
Stock option and restricted stock plans, net 17,039   17,039      
Sale of common stock, net (207)   (207)      
Equity based compensation costs 5,125   4,952     173
Retirement of common stock, net (in shares)   (219)        
Retirement of common stock, net (60,830)   (60,830)      
Changes in the redemption value of redeemable noncontrolling interest 1,223   1,051     172
Contributions from noncontrolling interest 125         125
Distributions to noncontrolling interest (15,241)         (15,241)
Redemptions of noncontrolling interest (in shares)   8        
Redemptions of noncontrolling interest (2,361)   (2,123)     (238)
Common stock dividends (287,052)     (287,052)    
Balance at period end (in shares) at Jun. 30, 2022   65,124        
Balance at period end at Jun. 30, 2022 6,006,585 $ 7 6,875,863 (1,073,577) 25,554 178,738
Balance at period beginning (in shares) at Mar. 31, 2022   65,332        
Balance at period beginning at Mar. 31, 2022 6,138,207 $ 7 6,930,072 (987,333) 14,237 181,224
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 61,690     57,054   4,636
Change in fair value of derivatives and amortization of swap settlements 11,812       11,416 396
Change in fair value of marketable debt securities, net (102)       (99) (3)
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   3        
Stock option and restricted stock plans, net 172   172      
Sale of common stock, net (66)   (66)      
Equity based compensation costs 2,662   2,572     90
Retirement of common stock, net (in shares)   (219)        
Retirement of common stock, net (60,830)   (60,830)      
Changes in the redemption value of redeemable noncontrolling interest 6,295   6,065     230
Distributions to noncontrolling interest (7,622)         (7,622)
Redemptions of noncontrolling interest (in shares)   8        
Redemptions of noncontrolling interest (2,335)   (2,122)     (213)
Common stock dividends (143,298)     (143,298)    
Balance at period end (in shares) at Jun. 30, 2022   65,124        
Balance at period end at Jun. 30, 2022 6,006,585 $ 7 6,875,863 (1,073,577) 25,554 178,738
Balance at period beginning (in shares) at Dec. 31, 2022   64,605        
Balance at period beginning at Dec. 31, 2022 5,895,116 $ 6 6,750,076 (1,080,176) 46,466 178,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 267,350     253,152   14,198
Change in fair value of derivatives and amortization of swap settlements 5,092       4,919 173
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   3        
Stock option and restricted stock plans, net 0          
Sale of common stock, net (125)   (125)      
Equity based compensation costs 7,646   7,387     259
Retirement of common stock, net (in shares)   (437)        
Retirement of common stock, net (95,657)   (95,657)      
Changes in the redemption value of redeemable noncontrolling interest (4,205)   (4,087)     (118)
Distributions to noncontrolling interest (16,033)         (16,033)
Redemptions of noncontrolling interest (in shares)   12        
Redemptions of noncontrolling interest (609)   (113)     (496)
Common stock dividends (296,570)     (296,570)    
Balance at period end (in shares) at Jun. 30, 2023   64,183        
Balance at period end at Jun. 30, 2023 5,762,005 $ 6 6,657,481 (1,123,594) 51,385 176,727
Balance at period beginning (in shares) at Mar. 31, 2023   64,182        
Balance at period beginning at Mar. 31, 2023 5,796,857 $ 6 6,657,183 (1,074,930) 36,522 178,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 105,756     99,620   6,136
Change in fair value of derivatives and amortization of swap settlements 15,386       14,863 523
Issuance of common stock under:            
Stock option and restricted stock plans, net (in shares)   1        
Stock option and restricted stock plans, net 0          
Sale of common stock, net (53)   (53)      
Equity based compensation costs 1,982   1,915     67
Changes in the redemption value of redeemable noncontrolling interest (1,147)   (1,160)     13
Distributions to noncontrolling interest (8,056)         (8,056)
Redemptions of noncontrolling interest (436)   (404)     (32)
Common stock dividends (148,284)     (148,284)    
Balance at period end (in shares) at Jun. 30, 2023   64,183        
Balance at period end at Jun. 30, 2023 $ 5,762,005 $ 6 $ 6,657,481 $ (1,123,594) $ 51,385 $ 176,727